Zepbound and Wegovy are approved for weight loss and weight management, while Mounjaro is ... Whether or not you have health insurance, cost may be a factor when you’re considering these drugs.

Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

The cost of the medication is not included ... This dual action can make it an effective option for weight management. Is Zepbound more effective for weight loss than Wegovy?

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Patrick Gilligan, a former Blue Cross Blue Shield executive, will succeed Cain Hayes, who left the financially troubled ...

There are 15 Connecticut-headquartered companies that made the 2025 Fortune 500 list of largest U.S. corporations. Here's the ...

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.